Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety/Efficacy Study of Oral Recombinant Human Lactoferrin in Renal Cell Carcinoma

This study has been completed.
Information provided by:
Agennix Identifier:
First received: November 1, 2004
Last updated: April 8, 2008
Last verified: April 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: March 2007
  Estimated Primary Completion Date: No date given